Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Farmasains : Jurnal Farmasi dan Ilmu Kesehatan Medfarm: Jurnal Farmasi dan Kesehatan
Rika Yulia
Universitas Surabaya
Biochemistry, Genetics & Molecular Biology Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Influence of historical use of antibiotics toward antibiotic resistance Fawandi Fuad Alkindi; Rika Yulia; Fauna Herawati; Abdul Kadir Jaelani
Farmasains : Jurnal Farmasi dan Ilmu Kesehatan Vol. 4 No. 1 (2019)
Publisher : Universitas Muhammadiyah Malang

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.22219/farmasains.v4i1.7901

Abstract

A WHO’s Global Surveillance of Antibiotic Resistance showed there is an increase of antimicrobial resistance in Asia between 2013 until 2014. Many studies showed that there is a correlation between prior antibiotic use with antimicrobial resistance case. The primary objective of this study is to analyze the relationship between prior antibiotic use with antimicrobial resistance. İt was a retrospective and descriptive study conducted at Bangil Regional General Hospital. The data collected from the medical record and microbiological test from the patient at the internal ward. Chi-square analysis used for the statistic. This study showed that prior antibiotic use increased 0,399 bigger for antimicrobial resistance rate (p=0,001). 
EVALUASI PERSENTASI KESESUAIAN DENGAN PEDOMAN 3 PENGGUNAAN ANTIBIOTIK DAN ANTIVIRUS PADA PASIEN COVID-19 NON VENTILATOR DI RSUD BANGIL Vincentina Yenny Triamyanti; Rika yulia; fauna herawati; Abdul Kadir Jaelani
MEDFARM: Jurnal Farmasi dan Kesehatan Vol 11 No 2 (2022): Medfarm: Jurnal Farmasi dan Kesehatan
Publisher : LPPM Akafarma Sunan Giri Ponorogo

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.48191/medfarm.v11i2.94

Abstract

Coronavirus (Covid-19) is an infectious disease caused by the SARS-CoV-2 virus. Most people infected with this virus develop mild to moderate respiratory illness and recover without requiring special treatment. However, people who are older and have comorbid will experience severe illness and require medical attention that can lead to death. The aimed of this study was to provide an overview of the evaluation of the use of antibiotics and antivirals in non-ventilated Covid-19 patients at Bangil Hospital. The method used is Defined Daily Dose (DDD/100 patient-days) and One Way ANOVA analysis. Based on the DDD/100 patient-days value, the most widely used antibiotic group was Moxifloxacin and the most common antiviral group was Remdesivir. Meanwhile, based on different tests on the use of antibiotics and antivirals, it is known that there is no significant difference between those who use antibiotics and do not use antibiotics and those who use antivirals without using antivirals. Thus it can be concluded that the use of antibiotics and antivirals has no effect on the patient's recovery rate.
Co-Authors Abdul Kadir Jaelani Abdul Kadir Jaelani Fauna Herawati Fauna Herawati Fawandi Fuad Alkindi Vincentina Yenny Triamyanti